Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
2,372.42
2,067.49
2,255.39
2,262.41
2,707.34
2,156.30
2,249.16
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,372.42
2,067.49
2,255.39
2,262.41
2,707.34
2,156.30
2,249.16
Raw Material Cost
1,583.38
1,362.58
1,314.23
1,207.79
1,482.63
1,370.98
1,542.42
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.44
6.27
5.76
4.95
6.46
8.19
6.80
Selling and Distribution Expenses
344.36
295.73
321.52
433.65
443.90
334.50
387.66
Other Expenses
15.33
11.15
15.34
15.76
12.32
15.75
17.39
Total Expenditure (Excl Depreciation)
2,087.51
1,776.05
1,794.90
1,804.03
2,056.15
1,871.19
2,110.73
Operating Profit (PBDIT) excl Other Income
284.9
291.4
460.5
458.40000000000003
651.2
285.1
138.4
Other Income
30.63
75.61
67.05
34.28
8.82
30.07
24.01
Operating Profit (PBDIT)
275.05
503.29
656.47
482.84
778.01
436.41
296.35
Interest
6.44
6.27
5.76
4.95
6.46
8.19
6.80
Exceptional Items
20.09
3.42
-2.15
-17.96
8.01
-4.63
-6.96
Gross Profit (PBDT)
789.04
704.91
941.16
1,054.63
1,224.71
785.32
706.74
Depreciation
0.00
192.33
192.33
181.18
181.18
180.69
180.69
Profit Before Tax
288.69
308.11
456.24
278.76
598.38
242.90
101.89
Tax
45.26
65.78
68.53
19.78
93.02
57.54
21.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
259.84
264.22
409.09
310.86
534.32
205.68
109.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
259.84
264.22
409.09
310.86
534.32
205.68
109.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-17.68
-24.90
-23.83
-49.17
-31.13
-29.68
-30.29
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
242.16
239.32
385.25
261.69
503.19
176.00
79.36
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
11,054.85
11,214.68
11,067.80
10,648.14
10,341.30
9,946.98
9,738.93
Earnings per share (EPS)
0.27
0.28
0.43
0.32
0.56
0.21
0.11
Diluted Earnings per share
0.27
0.28
0.43
0.32
0.56
0.21
0.11
Operating Profit Margin (Excl OI)
10.3%
11.38%
17.61%
11.82%
21.72%
10.46%
4.07%
Gross Profit Margin
12.17%
24.21%
28.76%
20.33%
28.79%
19.64%
12.56%
PAT Margin
10.95%
12.78%
18.14%
13.74%
19.74%
9.54%
4.88%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 14.75% vs -8.33% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 1.21% vs -37.89% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -42.86% vs -27.43% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 1.59% vs 8.62% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Zhejiang Medicine Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
2,372.42
0
2,372.42
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,372.42
0
2,372.42
Raw Material Cost
1,583.38
0
1,583.38
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.44
0
6.44
Selling and Distribution Expenses
344.36
0
344.36
Other Expenses
15.33
0.00
15.33
Total Expenditure (Excl Depreciation)
2,087.51
0
2,087.51
Operating Profit (PBDIT) excl Other Income
284.91
0.00
284.91
Other Income
30.63
0
30.63
Operating Profit (PBDIT)
275.05
0
275.05
Interest
6.44
0
6.44
Exceptional Items
20.09
0
20.09
Gross Profit (PBDT)
789.04
0
789.04
Depreciation
0.00
0
0.00
Profit Before Tax
288.69
0
288.69
Tax
45.26
0
45.26
Provisions and contingencies
0
0
0.00
Profit After Tax
259.84
0
259.84
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
259.84
0
259.84
Share in Profit of Associates
0
0
0.00
Minority Interest
-17.68
0
-17.68
Other related items
0.00
0.00
0.00
Consolidated Net Profit
242.16
0
242.16
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
11,054.85
0
11,054.85
Earnings per share (EPS)
0.27
0
0.27
Diluted Earnings per share
0.27
0
0.27
Operating Profit Margin (Excl OI)
10.30%
0%
0.00
10.30%
Gross Profit Margin
12.17%
0%
0.00
12.17%
PAT Margin
10.95%
0%
0.00
10.95%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 237.24 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 14.75% vs -8.33% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -12.37% vs 39.65% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 24.22 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 1.21% vs -37.89% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -51.87% vs 8,349.18% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.44 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -42.86% vs -27.43% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -68.23% vs 290.66% in Sep 2024
Quarterly - Interest
Interest 0.64 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 1.59% vs 8.62% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -1.54% vs -5.80% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.30%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
